These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Concluding remarks: can we explain the association of beta-agonists with asthma mortality? A hypothesis. Hancox RJ Clin Rev Allergy Immunol; 2006; 31(2-3):279-88. PubMed ID: 17085800 [TBL] [Abstract][Full Text] [Related]
5. The beta 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology. Sears MR; Taylor DR Drug Saf; 1994 Oct; 11(4):259-83. PubMed ID: 7848546 [TBL] [Abstract][Full Text] [Related]
6. Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response. Peters S Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S29-36. PubMed ID: 17925066 [TBL] [Abstract][Full Text] [Related]
8. Dose-response of inhaled drugs in asthma. An update. Clark DJ; Lipworth BJ Clin Pharmacokinet; 1997 Jan; 32(1):58-74. PubMed ID: 9012556 [TBL] [Abstract][Full Text] [Related]
9. The clinical use of beta-receptor agonists: for and against. Pauwels R Life Sci; 1993; 52(26):2171-9. PubMed ID: 8099698 [TBL] [Abstract][Full Text] [Related]
10. Long-acting beta 2-agonists. Role in primary care asthma treatment. D'Urzo AD Can Fam Physician; 1997 Oct; 43():1773-7. PubMed ID: 9356758 [TBL] [Abstract][Full Text] [Related]
11. Dual components of optimal asthma therapy: scientific and clinical rationale for the use of long-acting beta-agonists with inhaled corticosteroids. Naedele-Risha R; Dorinsky P; Craig TJ J Am Osteopath Assoc; 2001 Sep; 101(9):526-33. PubMed ID: 11575039 [TBL] [Abstract][Full Text] [Related]
12. Tolerance with beta 2-adrenoceptor agonists: time for reappraisal. Grove A; Lipworth BJ Br J Clin Pharmacol; 1995 Feb; 39(2):109-18. PubMed ID: 7742147 [TBL] [Abstract][Full Text] [Related]
13. The beta-agonist controversy. Taylor DR; Sears MR; Cockcroft DW Med Clin North Am; 1996 Jul; 80(4):719-48. PubMed ID: 8676612 [TBL] [Abstract][Full Text] [Related]
14. Combination corticosteroid/β-agonist inhaler as reliever therapy: a solution for intermittent and mild asthma? Beasley R; Weatherall M; Shirtcliffe P; Hancox R; Reddel HK J Allergy Clin Immunol; 2014 Jan; 133(1):39-41. PubMed ID: 24369798 [TBL] [Abstract][Full Text] [Related]
15. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources. Anis AH; Lynd LD; Wang XH; King G; Spinelli JJ; Fitzgerald M; Bai T; Paré P CMAJ; 2001 Mar; 164(5):625-31. PubMed ID: 11258208 [TBL] [Abstract][Full Text] [Related]
16. New developments in bronchodilator therapy. Nelson HS Curr Opin Pulm Med; 1996 Jan; 2(1):35-9. PubMed ID: 9363113 [TBL] [Abstract][Full Text] [Related]
17. Combined anticholinergic therapy in the management of acute asthma. Garrett JE Respirology; 1997; 2 Suppl 1():S17-8. PubMed ID: 9400690 [TBL] [Abstract][Full Text] [Related]
18. [Asthma therapy: are bronchodilators obsolete?]. Solèr M Schweiz Med Wochenschr; 1992 Mar; 122(13):455-60. PubMed ID: 1348869 [TBL] [Abstract][Full Text] [Related]
19. International trends in sales of inhaled fenoterol, all inhaled beta-agonists, and asthma mortality, 1970-1992. Lanes SF; Birmann B; Raiford D; Walker AM J Clin Epidemiol; 1997 Mar; 50(3):321-8. PubMed ID: 9120532 [TBL] [Abstract][Full Text] [Related]
20. End of the New Zealand asthma mortality epidemic. Pearce N; Beasley R; Crane J; Burgess C; Jackson R Lancet; 1995 Jan; 345(8941):41-4. PubMed ID: 7799709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]